Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019
22 avr. 2019 16h05 HE
|
Nuvectra Corporation
PLANO, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board
25 mars 2019 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Anthony P. Bihl, III as Chairman...
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results
28 févr. 2019 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the fourth quarter and full year...
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference
26 févr. 2019 08h30 HE
|
Nuvectra Corporation
PLANO, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and...
Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019
19 févr. 2019 08h30 HE
|
Nuvectra Corporation
PLANO, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra® Appoints Dr. Fred B. Parks as Chief Executive Officer
31 janv. 2019 17h01 HE
|
Nuvectra Corporation
PLANO, Texas, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Fred B. Parks, PhD, as Chief...
Nuvectra Provides Update on Virtis™ FDA PMA Submission
29 janv. 2019 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a medical device company dedicated to neuromodulation, announced today that the U.S. Food and Drug Administration...
Nuvectra® Announces Preliminary Unaudited Fourth Quarter and Full Year 2018 Revenue
07 janv. 2019 05h30 HE
|
Nuvectra Corporation
PLANO, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary unaudited revenue for the fourth quarter...
Nuvectra Announces Divesture of NeuroNexus Subsidiary
02 janv. 2019 08h30 HE
|
Nuvectra Corporation
PLANO, Texas, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has entered into an agreement effective...
Nuvectra Receives Full-Body MR-Conditional CE Mark Approval for Algovita®
12 déc. 2018 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received full-body MR-conditional approval...